Prof. Dr. Sompon Wanwimolruk
My Social Links

Prof. Dr. Sompon Wanwimolruk

Professor
Mahidol University, Thailand

Highest Degree
Ph.D. in Pharmacology and Toxicology from Mahidol University, Thailand

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Pharmacology
62%
Drug Metabolism
90%
Pharmacokinetics
75%
Biopharmaceuticals
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Wanwimolruk, S. and P. Wanwimolruk, 2011. Variable inhibitory effect of herbal supplements with different brands on human CYP1A2. Int. J. Pharmacol., (In Press). .
    Direct Link  |  
  2. Maliakal, P., U. Sankpal, R. Basha, C. Maliakal, A. Ledford and S. Wanwimolruk, 2011. Relevance of drug metabolizing enzyme activity modulation by tea polyphenols in the Inhibition of Esophageal tumorigenesis. Med. Chem., 7: 480-487.
    PubMed  |  Direct Link  |  
  3. Wanwimolruk, S., K. Wong and P. Wanwimolruk, 2009. Variable inhibitory effect of commercial herbal supplements with different brands on human cytochrome P450 CYP3A4. Drug Metabol. Drug Interact., 24: 17-35.
  4. Wanwimolruk, S. and B. Bernichi, 2008. Inhibitory effect of cranberry dietary supplements of different brands on human CYP1A2 enzyme. Proceeding of the 8th Asian Conference on Clinical Pharmacy, July 3-5, 2008, Surabaya, Indonesia. -.
  5. Wanwimolruk, S. and M.A. Alexanderm, 2007. Lipoic acid content in different brands of dietary supplement α-lipoic acid and its effect on human CYP1A2. Proceeding of the 2007 Annual Meeting of the American College of Clinical Pharmacy, October 14-17 2007, Denver, Colorado, USA. -.
  6. Moore, R., P. Yorgin, S. Wanwimolruk and N. Hamadam, 2007. In-vitro stability of antibiotics, recommended for the treatment of peritonitis in children, in peritoneal dialysis fluid. Proceeding of the 27th Annual Western States Conference for Pharmacy Residents, Fellows and Preceptors, May 29, June 1, 2007, Asilomar Conference Center, Pacific Grove, California. -.
  7. Wanwimolruk, S., K. Wong and P. Wanwimolruk, 2006. Variable inhibitory effect of commercial herbal supplements with different brands on human CYP3A4. Proceeding of the 6th Asian Conference on Clinical Pharmacy, July 6-8, 2006, Bangkok, Thailand. -.
  8. Wanwimolruk, S. and P.V. Marquez, 2006. Variations in content of active ingredients causing drug interactions, in grapefruit juice products sold in California. Drug Metabol. Drug Interact., 21: 233-243.
  9. Wanwimolruk, S. and P. Wanwimolruk, 2006. Inhibitory effect of herbal supplements of different brands on human CYP1A2. Proceeding of the American Association of Pharmaceutical Scientists Annual Meeting, October 29, November 2, 2006, San Antonio, Texas, USA. -.
  10. Wanwimolruk, S. and P. Wanwimolruk, 2006. Characterization of CYP1A enzyme in Adelie penguin liver. Compar. Biochem. Physiol., 144C: 148-154.
  11. Wanwimolruk, S., 2005. Characterization of ethoxyresorufin O-deethylase (CYP1A) in antarctic adelie penguins. Proceeding of the American Association of Pharmaceutical Scientists Annual Meeting, November 6-10, 2005, Nashville, Tennessee, USA. -.
  12. Wanwimolruk, S. and P. Wanwimolruk, 2005. Variable effect of selected herbal supplements of different brands on human cytochrome P450 (CYP) enzyme, CYP1A2. Proceeding of the 8th Annual Research Symposium, September 14, 2005, Loma Linda University. -.
  13. Wanwimolruk, S. and P.V. Marquez, 2004. Analysis of grapefruit juice products sold in California: Variation in content of flavonoids that cause drug interaction. Proceeding of the Asian Association of Schools of Pharmacy Conference, June 3-6, 2004, Beijing, China. -.
  14. Numata, M., J.P. Fawcett, R.J. Rosengren and S. Wanwimolruk, 2004. Ontogeny of hepatic microsomal 3-hydroxylation of quinine mediated by CYP3A in Adelie penguins. Compar. Biochem. Physiol., 138C: 53-58.
  15. Niwattisaiwong, N., X.X. Lou, P.F. Coville and S. Wanwimolruk, 2004. Effects of Chinese, Japanese and western tea on hepatic P450 enzyme activities in rats. Drug Metabol. Drug Interact., 20: 43-56.
  16. Pukrittayakamee, S, S. Wanwimolruk, K. Stepniewska, A. Jantra, S. Huyakorn, S. Looareesuwan and N.J. White, 2003. Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob. Agents Chemother., 47: 3458-3463.
  17. Pukrittayakamee, S, S. Prakongpan, S. Wanwimolruk, R. Clemens, S. Looareesuwan and N.J. White, 2003. Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria. Antimicrob. Agents Chemother., 47: 1509-1513.
  18. Wanwimolruk, S., M. Paine, S. Pusek and P.B. Watkins, 2002. Is quinine a suitable probe to assess the hepatic drug metabolizing enzyme CYP3A4? Br. J. Clin. Pharmacol., 54: 643-651.
  19. Wanwimolruk, S. and P.P. Maliakal, 2002. Herbal teas and their effects on drug metabolizing enzymes. Proceeding of the 2002 Annual Meeting of the American College of Clinical Pharmacy, October, 20-23 2002, Albuquerque, New Mexico, USA. -.
  20. Pukrittayakamee, S., P. Pitisuttithum, H. Zhang, A. Jantra, S. Wanwimolruk and N.J. White, 2002. Effects of cigarette smoking on quinine pharmacokinetics in malaria. Eur. J. Clin. Pharmacol., 58: 315-319.
  21. Maliakal, P.P., P.F. Coville and S. Wanwimolruk, 2002. Decreased hepatic drug metabolizing enzyme activity in rats with nitrosamine-induced tumours. Drug Metabol. Drug Interact., 19: 13-27.
  22. Wanwimolruk, S., M. Paine, S. Pusek and P.B. Watkins, 2001. Quinine as an in vivo probe for human CYP3A4. Proceeding of the 5th Congress of the European association for Clinical Pharmacology and Therapeutics, September 12-15 2001, Odense, Denmark. -.
  23. Numata, M., P.F. Coville, D.J. Saville, S. Wanwimolruk, 2001. Cytochrome P450s in penguins: A potential biomarker for environmental pollution. Proceedings of 3rd Oamaru Penguin Symposium, June 21-22, 2001, Oamaru, New Zealand -.
  24. Newton, P., A.J.H. Simpson, S. Wanwimolruk, P. Maliakal and L. Villegas et al., 2001. Oral quinine pharmacokinetics and dietary salt intake. Eur. J. Clin. Pharmacol., 57: 111-113.
  25. Maliakal, P.P., P.F. Coville and S. Wanwimolruk, 2001. Tea consumption modulates hepatic P450 and phase II enzymes in wistar rats. J. Pharm. Pharmacol., 53: 569-577.
  26. Maliakal, P.P. and S. Wanwimolruk, 2001. Effect of herbal tea on drug metabolizing enzymes in rats. J. Pharm. Pharmacol., 53: 1323-1329.
  27. Ho, P.C., D.J. Saville and S. Wanwimolruk, 2001. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J. Pharm. Pharmaceut. Sci., 4: 217-227.
    PubMed  |  Direct Link  |  
  28. Zhang, H., S. Wanwimolruk, P.F. Coville, J.C. Schofield, G. Williams, S.R. Haines and J.M. Suttie, 2000. Toxicological evaluation of New Zealand deer velvet powder: Part I: Acute and subchronic oral toxicity studies in rats. Food Chem. Toxicol., 38: 985-990.
  29. Zhang, H., C.W. Wong, P.F. Coville and S. Wanwimolruk, 2000. Effects of grapefruit juice flavonoid naringin on the pharmacokinetics of quinine in rats. Drug Metabol. Drug Interact., 17: 351-363.
  30. Viriyayudhakorn, S., S. Thitiarchakul, S. Nachaisit, P.C. Ho and S. Wanwimolruk, 2000. Pharmacokinetics of quinine in obesity. Trans. Royal Soc. Trop. Med. Hyg., 94: 425-428.
    Direct Link  |  
  31. Ho, P.C., K. Ghose, D.J. Saville and S. Wanwimolruk, 2000. Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers. Eur. J. Clin. Pharmacol., 56: 693-698.
  32. Ho, P.C., D.J. Saville, P.C. Coville and S. Wanwimolruk, 2000. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products. Pharmaceutica Acta Helvetiae, 74: 379-385.
    CrossRef  |  Direct Link  |  
  33. Ho, P.C., D.J. Saville and S. Wanwimolruk, 2000. Simultaneous HPLC analysis of S-and R-verapamil and metabolites, S-and R-norverapamil in human plasma. J. Liq. Chromatogr. Related Technol., 23: 1711-1723.
  34. Zhang, H., N. Ramsay, P.F. Coville and S. Wanwimolruk, 1999. Effects of erythromycin, rifampicin and isoniazid on the pharmacokinetics of quinine in rats. Pharm. Pharmacol. Commun., 5: 467-472.
  35. Wanwimolruk, S., P.C. Ho, D.J. Saville, P.F. Coville and K. Ghose, 1999. Effect of grapefruit juice on pharmacokinetics of S-and R-verapamil in healthy volunteers. Proceedings of The American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, November 13-18, 1999, New Orleans, USA -.
  36. Wanwimolruk, S., H. Zhang, P.C. Coville, D.J. Saville and L.S. Davis, 1999. In vitro hepatic metabolism of CYP3A-mediated drug, quinine in the Antarctic Adelie penguins. Compar. Biochem. Physiol., 124C: 301-307.
  37. Maliakal, P.P., P.F. Coville, J. Paxton and S. Wanwimolruk, 1999. Evidence of CYP3A-mediated metabolism of a novel antitumour agent, DACA. Proceedings of The American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, November 13-18, 1999, New Orleans, USA -.
  38. Ho, P.C., S.C. Chalcroft, P.F. Coville and S. Wanwimolruk, 1999. Grapefruit juice has no effect on quinine pharmacokinetics. Eur. J. Clin. Pharmacol., 55: 393-398.
  39. Wanwimolruk, S., S. Bhawan, P.F. Coville and S.C. Chalcroft, 1998. Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations. Eur. J. Clin. Pharmacol., 54: 431-435.
  40. Wanwimolruk, S., H. Zhang, P.F. Coville, D.J. Saville and L.S. Davis, 1998. Reduced ability of Antarctic Adelie penguins compared to humans to metabolize CYP3A substrate quinine. Proceedings of Conjoint Meeting of the Australasian Society of Clinical Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Sciences Association (APSA), December 13-16, 1998, Hobart, Australia -.
  41. Maliakal, P.P., P.F. Coville and S. Wanwimolruk, 1998. Modulation of hepatic P450 and phase II enzyme activities and blood lipid profile by green tea in rats. Proceedings of Conjoint Meeting of the Australasian Society of Clinical Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Sciences Association (APSA), December 13-16, 1998, Hobart, Australia -.
  42. Maliakal, P.P., P.F. Coville and S. Wanwimolruk, 1998. Decreased hepatic drug metabolizing enzyme activities in rats with nitrosamine-induced tumour. Proceedings of Conjoint Meeting of the Australasian Society of Clinical Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Sciences Association (APSA), December 13-16, 1998, Hobart, Australia -.
  43. Ho, P.C., X.X. Lou, J. Macauley, M. Grigor and S. Wanwimolruk, 1998. In vitro hepatic metabolism of CYP3A-mediated drugs, quinine and midazolam in Australian brushtail possums. Environ. Toxicol. Chem., 17: 317-324.
  44. Ho, P.C., S. Wanwimolruk and D.J. Saville, 1998. Inhibition of CYP3A4 activity in human liver microsomes by bioflavonoids and coumarin derivatives found in grapefruit juice. Proceedings of The American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, November 15-19, 1998, San Francisco, California -.
  45. Ho, P.C., D.J. Saville and S. Wanwimolruk, 1998. The content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice. Proceedings of the Australasian Society of Clinical Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 14-17, 1998, Hobart, Australia -.
  46. Ho, P.C., D.J. Saville and S. Wanwimolruk, 1998. Improved HPLC method for determination of a flavonoid naringin in grapefruit juice, without extraction. Pharm. Pharmacol. Commun., 4: 473-476.
  47. Zhang, H., P.F. Coville, R.J. Walker, J.O. Miners, D.J. Birkett and S. Wanwimolruk, 1997. Evidence for an involvement of human CYP3A in the 3-hydroxylation of quinine. Br. J. Clin. Pharmacol., 43: 245-252.
  48. Zhang, H., P.F. Coville and S. Wanwimolruk, 1997. Midazolam hydroxylase activities in liver microsomes from rats and human. Proceedings of The American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, November 2-6, 1997, Boston, Massachusetts -.
  49. Wanwimolruk, S., P.C. Ho and P.F. Coville, 1997. Large variation of naringin content in grapefruit juice sold in New Zealand. Proceedings of The Australasian Society of Clinical Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, September 4-5, 1997, Queenstown, New Zealand -.
  50. Wanwimolruk, S., H. Zhang, P.F. Coville, D.J. Saville and L.S. Davis, 1997. Reduced ability of Antarctic Adelie Penguins compared to humans to eliminate xenobiotics having a similar metabolic profile to quinine (P450IIIA substrates). Proceedings of Antarctica Research Seminar-New Zealand Activities in Antarctica 1997-98, March 27, 1998, Antarctic Research Centre, Victoria University, Wellington, New Zealand -.
  51. Roberts, M.S., S. Lipschitz, A.J. Campbell, S. Wanwimolruk, E.G. McQueen and M. McQueen, 1997. Modeling of subcutaneous absorption kinetics of infusion solutions in the elderly using technetium. J. Pharmacokinet. Biopharm., 25: 1-21.
  52. Maliakal, P.P., H.T. Trinh, P.F. Coville and S. Wanwimolruk, 1997. Effect of ginseng on P450 activities in rats. Proceedings of The Australasian Society of Clinical Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 1-3, 1997, Canberra, Australia -.
  53. Ho, P.C., P.F. Coville, S.C.W. Chalcroft and S. Wanwimolruk, 1997. Effect of grapefruit juice on quinine pharmacokinetics in healthy volunteers. Proceedings of The Australasian Society of Clinical Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 1-3, 1997, Canberra, Australia -.
  54. Zhao, X.L., H. Yokoyama, K. Chiba, S. Wanwimolruk and T. Ishizaki, 1996. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human liver microsomes and nine recombinant human cytochrome P450. J. Pharmacol. Exp. Ther., 279: 1327-1334.
  55. Zhang, H., P.F. Coville and S. Wanwimolruk, 1996. Sex and strain differences in hepatic quinine 3-hydroxylase activity in rats. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 8-13, 1996, Melbourne, Australia -.
  56. Zhang, H., P.F. Coville and S. Wanwimolruk, 1996. Metabolism of quinine in humans: Inhibition of quinine hydroxylation by antituberculosis and other antimalarial drugs. Proceedings of The Royal Australasian College of Physicians, Annual Clinical and Scientific Meeting, September 4-6, 1996, Dunedin, New Zealand -.
  57. Wanwimolruk, S., S.M. Wong, H. Zhang and P.F. Coville, 1996. Simultaneous determination of quinine and a major metabolite 3-hydroxyquinine in biological fluids by HPLC without extraction. J. Liq. Chromatogr., 19: 293-305.
  58. Wanwimolruk, S., C.S. Wong and P.C. Ho, 1996. In vitro metabolism of the antimalarial quinine in different animal species, cow, pig and sheep. Pharmaceut. Sci., 2: 295-298.
  59. Wanwimolruk, S. and E. Yuen, 1996. In vitro interactions between quinine and antimicrobial agents using human hepatic microsomal preparation. Proceedings of The 6th World Conference on Clinical Pharmacology and Therapeutics, August 4-9, 1996, Buenos Aries, Argentina -.
  60. Viriyayudhakorn, S. and S. Wanwimolruk, 1996. Pharmacokinetics of quinine in Asians (Thai) and white Caucasians. Asia Pac. J. Pharmacol., 11: 47-51.
  61. Niwattisaiwong, N., P.C. Coville and S. Wanwimolruk, 1996. Effects of Chinese, Japanese and Western tea on enzymes in rats. Proceedings of The Royal Australasian College of Physicians, Annual Clinical and Scientific Meeting, September 4-6, 1996, Dunedin, New Zealand -.
  62. Ho, P.C., P.C. Coville and S. Wanwimolruk, 1996. The analysis of naringin in grapefruit juice. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 8-13, 1996, Melbourne, Australia -.
  63. Ho, P.C., P.C. Coville and S. Wanwimolruk, 1996. Simple high-performance liquid chromatographic method for the analysis of naringin in grapefruit juice without extraction. Proceedings of The Royal Australasian College of Physicians, Annual Clinical and Scientific Meeting, September 4-6, 1996, Dunedin, New Zealand -.
  64. Zhang, H., S. Wanwimolruk and P.F. Coville, 1995. In vitro hepatic metabolism of quinine in rats. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 5-7, 1995, Adelaide, Australia -.
  65. Wanwimolruk, S., W. Kang, P.F. Coville, S. Viriyayudhakorn and S. Thitiarchakul, 1995. Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man. Br. J. Clin. Pharmacol., 40: 87-91.
  66. Wanwimolruk, S., S.M. Wong, P.F. Coville and R.J. Walker, 1995. Metabolism of quinine in man: Identification of a major metabolite in urine and effects of smoking and rifampicin pretreatment. J. Pharm. Pharmacol., 47: 957-963.
  67. Wanwimolruk, S., S.M. Wong, H. Zhang, P.F. Coville and R.J. Walker, 1995. Identification of a major metabolite of quinine in human urine and effects of smoking and rifampicin pretreatment. Proceedings of The 7th Southeast Asian/Western Pacific Regional Meeting of Pharmacologists, November 21-25, 1995, Manila, Philippines -.
  68. Wanwimolruk, S., M.R. Thou and D.J. Woods, 1995. Oxidation phenotyping of debrisoquine and proguanil in Khmers living in New Zealand. Proceedings of The 7th Southeast Asian/Western Pacific Regional Meeting of Pharmacologists, November 21-25, 1995, Manila, Philippines -.
  69. Wanwimolruk, S., M. Thou and D.J. Woods, 1995. Evidence for polymorphic oxidation of debrisoquine and proguanil in Khmer (Cambodian) population. Br. J. Clin. Pharmacol., 40: 166-169.
  70. Wanwimolruk, S., E.L. Pratt, J.R. Denton, S.C.W. Chalcroft, P.A. Barron and J.R. Broughton, 1995. Debrisoquine and proguanil oxidation polymorphisms in the New Zealand Maori population. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 5-7, 1995, Adelaide, Australia -.
  71. Wanwimolruk, S., E. Pratt, J. Denton, S. Chalcroft and J.R. Broughton, 1995. Evidence for the polymorphic oxidation of debrisoquine and proguanil in New Zealand Maori population. Pharmacogenetics, 5: 193-198.
  72. Wanwimolruk, S., 1995. Polymorphic drug oxidation in Asians and non-Caucasian populations. Proceedings of A Symposium Session at the 7th Southeast Asian/Western Pacific Regional Meeting of Pharmacologists, November 21-25, 1995, Manila, Philippines -.
  73. Wanwimolruk, S., 1995. Clinical pharmacokinetics and metabolism of antimalarial quinine. Proceedings of A Symposium Session at the 7th Southeast Asian/Western Pacific Regional Meeting of Pharmacologists, November 21-25, 1995, Manila, Philippines -.
  74. Wanwimolruk, S. and E.L. Pratt, 1995. A simple HPLC assay for proguanil and its active metabolite cycloguanil: Application to oxidation phenotyping. J. Liq. Chromatogr., 18: 4097-4105.
  75. Ho, P.C., S. Wanwimolruk, X.X. Luo and M. Grigor, 1995. In vitro hepatic metabolism of CYP3A-medicated drugs, quinine and midazolam in Australian brushtail possum. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 5-7, 1995, Adelaide, Australia -.
  76. Zhang, H., S. Wanwimolruk, D.G. Ferry and N. Ramsay, 1994. Effect of erythromycin pretreatment on the pharmacokinetics of quinine in rats. Proceedings of The Australasian Pharmaceutical Sciences Association (APSA) Meeting, December 3-5, 1994, Auckland, New Zealand -.
  77. Zhang, H., S. Wanwimolruk and P.F. Coville, 1994. Lack of effect of rifampicin and isoniazid on the pharmacokinetics of quinine in rats. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 4-7, 1994, Auckland, New Zealand -.
  78. Wanwimolruk, S., S.M. Wong, P.F. Coville and R.J. Walker, 1994. In vitro hepatic microsomal metabolism of quinine: identification of P450 enzymes responsible for quinine metabolism. Proceedings of The 22th International Congress of Pharmacology, July 24-29, 1994, Montreal, Canada -.
  79. Wanwimolruk, S., H. Zhang, P.F. Coville and R.J. Walker, 1994. Further evidence for an involvement of human P450IIIA in the hepatic metabolism of quinine. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 4-7, 1994, Auckland, New Zealand -.
  80. Shen, J. and S. Wanwimolruk, 1994. Effects of umbilical flow rate and protein binding on placental transfer of aspirin and salicylic acid in pregnant guinea pig. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 4-7, 1994, Auckland, New Zealand -.
  81. Luo, X.X., S. Wanwimolruk, M.S. Roberts and A. Swan, 1994. In vitro protein binding of naproxen to synovial tissues from arthritic patients. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 4-7, 1994, Auckland, New Zealand -.
  82. Kang, W., S. Wanwimolruk, P.F. Coville, S. Viriyayudhakorn and S. Thitiarchakul, 1994. Effects of rifampicin and isoniazid on the pharmacokinetics of quinine in man.Effects of rifampicin and isoniazid on the pharmacokinetics of quinine in man. Proceedings of The Australasian Pharmaceutical Sciences Association (APSA) Meeting, December 3-5, 1994, Auckland, New Zealand -.
  83. Wanwimolruk, S., S.M. Wong, P.F. Coville, S. Viriyayudhakorn and S. Thitiarchakul, 1993. Cigarette smoking enhances the elimination of quinine: a finding not predicted by in vitro studies? Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, December 1993, Brisbane, Australia -.
  84. Wanwimolruk, S., S.M. Wong, P.F. Coville, S. Viriyayudhakorn and S. Thitiarchakul, 1993. Cigarette smoking enhances the elimination of quinine. Br. J. Clin. Pharmacol., 36: 610-614.
  85. Wanwimolruk, S., M. Kepple, S. Nyika, D.G. Ferry and C.R. Clark, 1993. Effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats. J. Pharm. Pharmacol., 45: 618-621.
  86. Shen, J., S. Wanwimolruk, M.S. Roberts, P.D. Wilson and R.J. Seddon, 1993. Clinical trial of slow-release formulation of acetylsalicylic acid in patients at risk for preeclampsia. Br. J. Clin. Pharmacol., 35: 664-667.
  87. Zoest, A.R., C.T. Hung, F.C. Lam, R.B. Taylor and S. Wanwimolruk, 1992. Prediction of retention in reversed phase ion-pair chromatography using sodium dodecyl sulphate as pairing ion. J. Liq. Chromatogr, 15: 395-410.
  88. Zoest, A.R. and S. Wanwimolruk, 1992. Diltiazem: A sensitive HPLC assay and application to pharmacokinetic study. J. Liq. Chromatogr, 15: 1277-1287.
  89. Wanwimolruk, S., S. Nyika, M. Kepple, D.G. Ferry and C.R. Clark, 1992. The effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats. Proceedings of ASCEPT (NZ) Meeting, May, 1992, Auckland, New Zealand -.
  90. Wanwimolruk, S., S. Chalcroft, P.F. Coville and A.J. Campbell, 1992. Pharmacokinetics of quinine in young and elderly subjects. Proceedings of The 5th World Conference on Clinical Pharmacology and Therapeutics, July 26-31, 1992, Yokohama, Japan -.
  91. Wanwimolruk, S., J.R. Denton, D.G. Ferry, M. Beasley and J.R. Broughton, 1992. Polymorphism of debrisoquine oxidation in New Zealand Caucasians. Eur. J. Clin. Pharmacol., 43: 349-350.
  92. Wanwimolruk, S., G. Edwards, S.A. Ward and A.M. Breckenridge, 1992. The binding of the antimalarial arteether to human plasma proteins in vitro. J. Pharm. Pharmacol., 44: 940-942.
  93. Wanwimolruk, S., G. Edwards, S.A. Ward and A.M. Breckenridge, 1992. The binding of antimalarial arteether to human plasma proteins. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists NZ Meeting, May, 1992, Auckland, New Zealand -.
  94. Wanwimolruk, S. and S. Chalcroft, 1992. Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics of quinine. Proceedings of The 5th World Conference on Clinical Pharmacology and Therapeutics, July 26-31, 1992, Yokohama, Japan -.
  95. Wanwimolruk, S. and J.R. Denton, 1992. Plasma protein binding of quinine: Binding to human serum albumin, &alfa;1-acid glycoprotein and plasma from patients with malaria. J. Pharm. Pharmacol., 44: 806-811.
    CrossRef  |  Direct Link  |  
  96. Luyk, N.H., M. Zacharias and S. Wanwimolruk, 1992. Bolus dose with continuous infusion of midazolam as sedation for outpatient surgery. Int. J. Oral Maxillofac. Surg., 21: 172-175.
  97. Zoest, A.R., S. Wanwimolruk, J. Walton and C.T. Hung, 1991. A rapid isocratic HPLC assay for dipyridamole using a microbore column technique. J. Liq. Chromatogr., 14: 1967-1975.
    Direct Link  |  
  98. Wanwimolruk, S., S.Z. Wanwimolruk and A.R. Zoest, 1991. Sensitive HPLC assay for ketoprofen in human plasma and its application to pharmacokinetic study. J. Liq. Chromatogr. Clin. Anal., 14: 3685-3694.
    Direct Link  |  
  99. Wanwimolruk, S., S.Z. Wanwimolruk and A.R. Zoest, 1991. A simple and sensitive HPLC assay for the analysis of piroxicam in plasma and its application to bioavailability study. J. Liq. Chromatogr., 14: 2373-2381.
    Direct Link  |  
  100. Wanwimolruk, S., S. Lipschitz and M.S. Roberts, 1991. Pharmacokinetics and bioavailability of Naprosyn CR 500 mg tablet, a new controlled-release formulation of naproxen, after single and multiple dosing. Int. J. Pharmaceut., 75: 55-62.
    Direct Link  |  
  101. Wanwimolruk, S., S. Kaewvichit, O. Tanthayaphinant, C. Surwanraj and A. Oranratnachai, 1991. Lack of effect of oral contraceptive use on the pharmacokinetics of quinine. Br. J. Clin. Pharmacol., 31: 179-181.
    Direct Link  |  
  102. Wanwimolruk, S., S. Chalcroft, P.F. Coville and A.J. Campbell, 1991. Pharmacokinetics of quinine in young and elderly subjects. Trans. R. Soc. Trop. Med. Hyg., 85: 714-717.
    PubMed  |  
  103. Wanwimolruk, S., S. Chalcroft, P.F. Coville and A.J. Campbell, 1991. Pharmacokinetics of quinine in elderly. Proceedings of The 6th Southeast Asia and Western Pacific Regional Pharmacology Meeting, June 30-July 4, 1991, Hong Kong -.
  104. Wanwimolruk, S., J. Shen, M.S. Roberts and R.D. Purves, 1991. Placental transfer and pharmacodynamics of β-blockers in pregnant sheep. Proceedings of British Pharmacological Society Meeting, December 16-18, 1991, London University, London, UK -.
  105. Wanwimolruk, S., D.J. Birkett and P.M. Brooks, 1991. Structure-activity relationships for protein binding of a series of basic non-steroidal anti-inflammatory drugs. Biochem. Pharmacol., 41: 148-151.
    Direct Link  |  
  106. Wanwimolruk, S., A.R. Zoest, S.Z. Wanwimolruk and C.T. Hung, 1991. A sensitive high-performance liquid chromatographic determination of the analysis of famotidine in human plasma: Application to pharmacokinetic study. J. Chromatogr, 572: 227-238.
    Direct Link  |  
  107. Wanwimolruk, S., A.R. Zoest and C.T. Hung, 1991. A sensitive HPLC determination of the analysis of famotidine in plasma: Application to pharmacokinetic study. Proceedings of 3rd International Symposium on Pharmaceutical and Biomedical Analysis, April 28-May 1, 1991, Boston, USA -.
  108. Wanwimolruk, S., 1991. Rapid high-performance liquid chromatographic analysis and stability study of hydrocortisone 17-butyrate in cream preparations. Pharmaceut. Res., 8: 547-549.
    Direct Link  |  
  109. Wanwimolruk, S., 1991. Microbore liquid chromatography for analysis of plasma pindolol concentrations. J. Liq. Chromatogr. Clin. Anal., 14: 1699-1706.
    Direct Link  |  
  110. Wanwimolruk, S., 1991. High-performance liquid chromatographic analysis of desipramine in human plasma using a microbore column technique. J. Liq. Chromatogr. Clin. Anal., 14: 1805-1811.
    Direct Link  |  
  111. Wanwimolruk, S., 1991. A sensitive high-performance liquid chromatographic determination of clopamide in plasma. J. Liq. Chromatogr. Clin. Anal., 14: 1707-1714.
    Direct Link  |  
  112. Wanwimolruk, S. and S. Chalcroft, 1991. Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics of quinine. Br. J. Clin. Pharmacol., 32: 617-620.
    Direct Link  |  
  113. Wanwimolruk, S. and J.E. Murphy, 1991. Effects of monitoring drug concentrations through lines used to administer the drugs: An in vitro study. Ther. Drug Monitor, 13: 443-447.
    Direct Link  |  
  114. Shen, J., S. Wanwimolruk, R.G. Mills and M.S. Roberts, 1991. Response to β-blockers in maternal and fetal rat hearts in vitro. Life Sci., 48: 1737-1743.
  115. Shen, J., S. Wanwimolruk, C.T. Hung and A.R. Zoest, 1991. Quantitative analysis of β-blockers in human plasma by reversed-phase ion-pair HPLC using a microbore column technique. J. Liq. Chromatogr., 14: 777-793.
    Direct Link  |  
  116. Shen, J., S. Wanwimolruk and M.S. Roberts, 1991. Novel direct high-performance liquid chromatographic (HPLC) method for determination of salicylate glucuronide conjugates in human urine. J. Chromatogr., 565: 309-320.
    Direct Link  |  
  117. Shen, J., S. Wanwimolrak, R.D. Purves, E.G. McQueen and M.S. Roberts, 1991. Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose. J. Pharm. Pharmacodyn., 19: 575-595.
    CrossRef  |  
  118. Shen, J. and S. Wanwimolruk, 1991. A simple and sensitive HPLC method for antipyrine in plasma. J. Liq. Chromatogr. 14: 2801-2808.
    Direct Link  |  
  119. Sen, A.C., K. Matsuyama, S. Wanwimolruk and J.H. Perrin, 1991. Observations of conformational changes in human serum albumin following removal of fatty acid by charcoal. J. Pharm. Biomed. Anal., 9: 781-784.
    Direct Link  |  
  120. Luyk, N.H., M. Zacharias and S. Wanwimolruk, 1991. Continuous infusion versus bolus injection of midazolam for third molar surgery. Proceedings of American Association of Oral and Maxillofacial Surgery Conference, September, 1991, Chicago, USA -.
  121. Lipschitz, S., S. Wanwimolruk, A.J. Campbell, M.S. Roberts, M. McQueen and E.G. McQueen, 1991. Subcutaneous fluid administration in elderly subjects: Validation of an under-used technique. J. Am. Geriatr. Soc., 39: 6-9.
    Direct Link  |  
  122. Zoest, A.R., S. Wanwimolruk and C.T. Hung, 1990. Simple high-performance liquid chromatographic method for the analysis of quinine in human plasma without extraction. J. Liq. Chromatogr., 13: 3481-3491.
  123. Wanwimolruk, S., S. Lipschitz, M.S. Roberts and J.A. Campbell, 1990. Pharmacokinetics and bioavailability of Naprosyn CR 500 mg tablet, a new controlled-release formulation of naproxen. Proceeings of ASCEP (NZ) Meeting, May, 1990, Christchurch, New Zealand -.
  124. Wanwimolruk, S., S. Lipschitz, M.S. Roberts and J.A. Campbell, 1990. Evaluation of the relative bioavailability of 500 mg Naprosyn (naproxen) controlled-release tablets. Proceedings of The 21th International Congress of Pharmacology (IUPHAR) Meeting, July, 1990, Amsterdam, The Netherlands -.
  125. Wanwimolruk, S., E.J.D. Lee and P. Patamasucon, 1990. Evidence for the polymorphic oxidation of debrisoquine in the Thai population. Br. J. Clin. Pharmacol., 29: 244-247.
    Direct Link  |  
  126. Wanwimolruk, S., 1990. A simple isocratic high-performance liquid chromatographic (HPLC) determination of naproxen in human plasma using a microbore column technique. J. Liq. Chromatogr., 13: 1611-1625.
    Direct Link  |  
  127. Wanwimolruk, S. and D.G. Ferry, 1990. Rapid high-performance liquid chromatographic method for the analysis of debrisoquine and 4-hydroxydebrisoquine in urine without derivatisation. J. Liq. Chromatogr., 13: 961-968.
    Direct Link  |  
  128. Shen, J., S. Wanwimolruk, R.G. Mills and M.S. Roberts, 1990. In vitro response to β-blockers in maternal and fetal rat hearts. Proceedings of ASCEP (NZ) Meeting, May, 1990, Christchurch, New Zealand -.
  129. Shen, J-J, S. Wanwimolruk, C.R. Clark and M.S. Roberts, 1990. A sensitive ion-pair high-performance liquid chromatographic method for assaying aspirin, salicylic acid and its metabolites in human plasma. J. Liq. Chromatogr., 13: 751-761.
    Direct Link  |  
  130. Roberts, M.S., J. Shen, S. Wanwimolruk, R.G. Mills, M. Walton and R.D. Purves, 1990. Response to β-blockers in maternal and fetal hearts. Proceedings of ASCEP Meeting, December, 1990, Melbourne, Australia -.
  131. Kaewvichit, S., S. Wanwimolruk, O. Tanthayaphinant, C. Suwanraj and A. Oranratnachai, 1990. Effect of oral contraceptives on the pharmacokinetics of quinine. Proceedings of ASCEP (NZ) Meeting, May, 1990, Christchurch, New Zealand -.
  132. Hung, C.T., S. Wanwimolruk, A.R. Zoest and F.C. Lam, 1990. A study of the pharmacokinetics and pharmacodynamics of indapamide. Proceedings of ASCEP Meeting, December, 1990, Melbourne, Australia -.
  133. Denton, J. and S. Wanwimolruk, 1990. Protein binding of quinine. Proceedings of ASCEP (NZ) Meeting, May, 1990, Christchurch, New Zealand -.
  134. Wanwimolruk, S., D.G. Ferry, L.R. Gazeley, M. Beasley and J.R. Broughton, 1989. Debrisoquine oxidation polymorphism in Maori and South Pacific Polynesians: Preliminary study. Proeedings of ASCEP Meeting, December, 1989, Sydney, Australia -.
  135. Wanwimolruk, S. and D.G. Ferry, 1989. Rapid High-Performance Liquid Chromatographic (HPLC) method for the analysis of debrisoquine and 4-hydroxydebrisoquine in human urine, without derivatisation. Proceedings of ASCEP (NZ) Meeting, August, 1989, Christchurch, New Zealand -.
  136. Wanwimolruk, S. and D.G. Ferry, 1989. Rapid HPLC method for the analysis of debrisoquine and 4-hydroxydebrisoquine in human urine, without derivatisation. Proceedings of ASCEP Meeting, December, 1989, Sydney, Australia -.
  137. Shen, J., S. Wanwimolruk and M.S. Roberts, 1989. A novel direct High-Performance Liquid Chromatographic (HPLC) method for determination of salicylate glucuronide metabolites in human urine. Proceedings of ASCEP (NZ) Meeting, August, 1989, Christchurch, New Zealand -.
  138. Shen, J., S. Wanwimolruk and M.S. Roberts, 1989. A novel direct HPLC method for determination of salicylate glucuronide metabolites in human urine. Proceedings of ASCEP Meeting, December, 1989, Sydney, Australia -.
  139. Shen, J. and S. Wanwimolruk, 1989. Quantitative analysis of β-blockers in human plasma by High-Performance Liquid Chromatography (HPLC) using a microbore column. Proceedings of ASCEP Meeting, December, 1989, Sydney, Australia -.
  140. Roberts, M.S., J. Shen, S. Wanwimolruk, R.D. Purves and E.G. McQueen, 1989. Salicylate pharmacokinetics revisited. Proceedings of ASCEP Meeting, December, 1989, Sydney, Australia -.
  141. Wanwimolruk, S., P. Patamasucon and E.J.D. Lee, 1988. Polymorphism of debrisoquine hydroxylation in Thai population. Proceedings of ASCEP Meeting, December, 1988, Adelaide, Australia -.
  142. Wanwimolruk, S., J. Shen, C.R. Clark and M.S. Roberts, 1988. A sensitive ion-pair HPLC method for assaying aspirin, salicylic acid and metabolites in human plasma. Proceedings of ASCEP Meeting, December, 1988, Adelaide, Australia -.
  143. Wanwimolruk, S. and G. Levy, 1988. Effect of experimental arthritis on the pharmacodynamics of phenobarbital in rats. Proceedings of ASCEP Meeting, December 1988, Adelaide, Australia -.
  144. Wanwimolruk, S. and G. Levy, 1988. Effect of experimental arthritis on the pharmacodynamics of phenobarbital in rats. Proceedings of ASCEP (NZ) Meeting, August, 1988, Dunedin, New Zealand -.
  145. Shen, J., S. Wanwimolruk, C.R. Clark and M.S. Roberts, 1988. A sensitive ion-pair HPLC method for aspirin, salicylic acid and metabolites in human plasma. Proceedings of ASCEP (NZ) Meeting, August, 1988, Dunedin, New Zealand -.
  146. Roberts, M.S., L.J. Schep and S. Wanwimolruk, 1988. Modelling changes in hepatic extraction with flow rate in the isolated perfused rat liver. Proceedings of ASCEP Meeting, December, 1988, Adelaide, Australia -.
  147. Wanwimolruk, S., M. Pongamarutai, M. Sunbhanich and E.J.D. Lee, 1987. Preliminary study of debrisoquine hydroxylation polymorphism in Thai population. Proceedings of The 2nd South East Asian Drug Metabolism Workshop, November, 1987, Singapore -.
  148. Wanwimolruk, S. and G. Levy, 1987. Kinetics of drug action in disease states: XXII. Effects of oral contraceptive steroids on the pharmacodynamics of ethanol in rats. Pharmaceut. Res., 4: 240-243.
    Direct Link  |  
  149. Wanwimolruk, S. and G. Levy, 1987. Kinetics of drug action in disease states: XX. Effects of acute starvation on the pharmacodynamics of phenobarbital, ethanol and pentylenetetrazol in rats and effects of refeeding and diet composition. J. Pharmacol. Exp. Ther., 242: 166-172.
    Direct Link  |  
  150. Wanwimolruk, S. and G. Levy, 1987. Effect of age on the pharmacodynamics of phenobarbital and ethanol in rats. J. Pharm. Sci., 76: 503-507.
    Direct Link  |  
  151. Wanwimolruk, S., M. Pongmarutai, M. Sunbhanich and P. Patamusucon, 1986. Effects of cimetidine and ranitidine on pharmacokinetics of quinine. Br. J. Clin. Pharmacol., 22: 346-350.
    Direct Link  |  
  152. Wanwimolruk, S. and G. Levy, 1985. Effect of acute starvation on the pharmacodynamics of phenobarbital and ethanol in rats. Proceedings of The American Pharmaceutical Association Academy of Pharmaceutical Sciences (APhA) Meeting, October, 1985, Minneapolis, USA -.
  153. Wanwimolruk, S. and D.J. Birkett, 1985. Structure binding relationships for sites I and II on albumin. Proceedings of The 20th Symposia Medica Hoeschst: “Protein Binding and Drug Transport”, September, 1985, Algarve, Portugal -.
  154. Birkett, D.J. and S. Wanwimolruk, 1985. Albumin as a specific binding protein for drugs and endogenous compounds. Proceedings of The 20th Symposia Medica Hoechst: “Protein Binding and Drug Transport”, September, 1985, Algarve, Portugal -.
  155. Wing, L.H.M., J.O. Miners, D.J. Birkett, T. Foenander, K. Lillywhite and S. Wanwimolruk, 1984. Lidocaine disposition-sex differences and the effect of cimetidine. Clin. Pharmacol. Ther., 35: 695-701.
    Direct Link  |  
  156. Wanwimolruk, S., D. Thomas, D.J. Birkett, J.O. Miners and P.M. Brooks, 1984. Clinical pharmacology of GP53,633-a new non-steroidal antiinflammatory drug-in patients with rheumatoid arthritis. Agents Actions, 15: 424-427.
    Direct Link  |  
  157. Plummer, J.L., S. Wanwimolruk, M.A. Jenner, P.M. Hall and M.J. Cousins, 1984. Effects of cimetidine and ranitidine on halothane metabolism and hepatotoxicity in an animal model. Drug Metab. Dispos., 12: 106-110.
    Direct Link  |  
  158. Kilpatrick, C.J., S. Wanwimolruk and L.H.M. Wing, 1984. Plasma concentrations of unbound phenytoin in the management of epilepsy. Br. J. Clin. Pharmacol., 17: 539-546.
    Direct Link  |  
  159. Wanwimolruk, S., D.J. Birkett and P.M. Brooks, 1983. Structure-activity relationships for protein binding of a series of new basic non-steroidal anti-inflammatory drugs. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, May, 1983, Auckland, New Zealand -.
  160. Wanwimolruk, S., D.J. Birkett and P.M. Brooks, 1983. Structural requirement for drug binding to site II on human serum albumin. Mol. Pharmacol., 24: 458-463.
    Direct Link  |  
  161. Wanwimolruk, S., D.J. Birkett and P.M. Brooks, 1983. Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. Br. J. Clin. Pharmacol., 15: 91-94.
    Direct Link  |  
  162. Roberts, M.S., R.H. Rumble, S. Wanwimolruk, D. Thomas and P.M. Brooks, 1983. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease. Eur. J. Clin. Pharmacol., 25: 253-261.
    Direct Link  |  
  163. Wanwimolruk, S., D.J. Birkett and P.M. Brooks, 1982. Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clin. Pharmacokinet, 7: 85-92.
    Direct Link  |  
  164. Wanwimolruk, S., D.J. Birkett and P.M. Brooks, 1982. Protein binding of GP53,633: A basic non-steroidal anti-inflammatory drug. Biochem. Pharmacol., 31: 3737-3743.
    Direct Link  |  
  165. Wanwimolruk, S., D.J. Birkett and L.M.H. Wing, 1982. Comparison of three methods for the routine measurement of phenytoin free fraction during therapeutic drug monitoring. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1982, Sydney, Australia -.
  166. Wanwimolruk, S. and D.J. Birkett, 1982. The effect of N-B transition of human serum albumin on the specific drug-binding sites. Biochim. Biophys. Acta., 709: 247-255.
    Direct Link  |  
  167. Wanwimolruk, S. and D.J. Birkett, 1982. Structure-activity relationships for protein binding of radiocontrast agents. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1982, Sydney, Australia -.
  168. Plummer, J.L., S. Wanwimolruk, M.A. Jenner, P.M. Hall and M.J. Cousins, 1982. Effects of cimetidine and ranitidine on halothane metabolism and hepatotoxicity. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1982, Sydney, Australia -.
  169. Miners, J.O., T. Foenander, S. Wanwimolruk. A.S. Gallus and D.J. Birkett, 1982. The effect of sulphinpyrazone on oxidative drug metabolism in man: Inhibition of tolbutamide elimination. Eur. J. Clin. Pharmacol., 22: 321-326.
    Direct Link  |  
  170. Miners, J.O., T. Foenander, S. Wanwimolruk, A.S. Gallus and D.J. Birkett, 1982. Interaction of sulphinpyrazone with warfarin. Eur. J. Clin. Pharmacol., 22: 327-331.
    Direct Link  |  
  171. Kilpatrick, C., S. Wanwimolruk and L.M.H. Wing, 1982. Plasma concentrations of unbound phenytoin in the management of epilepsy. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1982, Sydney, Australia -.
  172. Wing, L.M.H., J.O. Miners, T. Foenander, S. Wanwimolruk and D.J. Birkett, 1981. Lignocaine disposition-sex differences and the effect of cimetidine. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1981, Adelaide, Australia -.
  173. Wanwimolruk, S., P.M. Brooks and D.J. Birkett, 1981. Plasma and synovial fluid protein binding of Non-Steroidal Anti-Inflammatory Drugs (NSAID) in arthritic patients. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1981, Adelaide, Australia -.
  174. Wanwimolruk, S., D.J. Birkett and P.M. Brooks, 1981. Structural requirements and characteristics for drug binding to site II on Human Serum Albumin (HSA). Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1981, Adelaide, Australia -.
  175. Rumble, R.H., M.S. Roberts and S. Wanwimolruk, 1981. Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction. J. Chromatogr., 225: 252-260.
    Direct Link  |  
  176. Miners, J.O., D.J. Birkett, A.S. Gallus, S. Wanwimolruk, P.T. Foenander and J. Attwood, 1981. Effects of sulphinpyrazone on the elimination of tolbutamide and theophylline. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1981, Adelaide, Australia -.
  177. Brooks, P.M., M.S. Roberts, R.H. Rumble, D. Thomas and S. Wanwimolruk, 1981. Aspirin and salicylate pharmacokinetics in the aged and in patients with alcoholic liver disease. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1981, Adelaide, Australia -.
  178. Wanwimolruk, S., P.M. Brooks and D.J. Birkett, 1980. Protein binding of a new, basic non-steroidal anti-inflammatory drug (NSAID), GP 53,633 and its major metabolites. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, December, 1980, Canberra, Australia -.
  179. Wanwimolruk, S., D.J. Birkett and P.M. Brooks, 1980. Protein binding of non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Proceedings of The Australasian Society of Clinical and Experimental Pharmacologists Meeting, May, 1980, Melbourne, Australia -.
  180. Sadavongvivad, C., P. Sanvarida, S. Saneha, S. Wanwimolruk and J. Satayavivad, 1979. Adrenoceptor subtypes and their cholinoceptor-induced blockades in mammalian atria. Gen. Pharmacol., 10: 465-470.
    Direct Link  |